Title
Category
Credits
Event date
Cost
  • Neurology
  • Sleep
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Individuals with narcolepsy may experience not only academic, social, and occupational consequences but also dangerous driving or other accidents, meaning that effective treatment is critical. Here, review the evidence on treatment strategies.
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
After several years, patients with Parkinson disease often experience OFF episodes, or periods each day when medication efficacy “wears off.” How can you increase their ON time? In this CME activity, follow along as 2 experts review evidence on treatment.
  • Alzheimer Disease
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Psychotic Disorders
  • Violence/Aggression
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
When you treat patients with dementia-related psychosis, do you evaluate the burden on carers, too? If they feel discomfort, fear, or depression, how would you help them? Learn from an expert in this brief CME activity.
  • Antipsychotics
  • Movement Disorders
  • Neurology
  • Patient/Physician Communication
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Do you know how to talk with your patients about the risk for tardive dyskinesia? Follow along as Dr Nierenberg offers tips for clear communication.
  • Anticonvulsants
  • Epilepsy
  • Neurology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Drs Detyniecki and Penovich identify the need for emergency seizure response plans and the new rescue treatment options that may easily be used by patients with epilepsy and their caregivers.
  • Anticonvulsants
  • Epilepsy
  • Neurology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Seizure clusters take a toll on patients’ emotional wellbeing, work, and quality of life. Learn from experts about new rescue treatments.
  • Alzheimer Disease
  • Neurology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
How do investigational drugs for Alzheimer disease differ from those currently prescribed to patients? Dr Burke shares her insights.
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.
  • Delivery of Care
  • Diagnostic Tools
  • Geriatric Psychiatry
  • Neurology
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What diagnostic criteria and assessment tools would you use for dementia-related psychosis? What strategies may help when discussing psychosis with patients’ family members? Dr Ballard considers these topics in this brief CME activity.
  • Delivery of Care
  • Movement Disorders
  • Neurology
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Measurement-based care has been found to be effective in patients with psychiatric conditions. Learn how to employ MBC for patients with tardive dyskinesia.

Pages